Felix Biotechnology specializes in targeted antimicrobial technologies, developing biotherapeutic solutions for the heath care industry and similar relevant applications. “Leveraging the potential of our technology across a range of applications allows us to have the biggest impact possible,” says Natalie Ma, Head of Business Development at Felix Biotechnology, is a recent media release about the partnership. “And,” she adds, “we are very excited to be working with a leader in the personal care and cosmetic space like Biocogent on this project.”
The San Francisco, California – based company was founded in 2019 and works closely with researchers at both Yale University and the University of California, Berkeley to address “urgent microbial challenges in human health and beyond.”
Biocogent partners with Felix Biotech on new skin care tech
Biocogent in a New York State – based personal care and cosmetic ingredient maker. The company, founded by Joseph Ceccoli, got its start in 2010 and today has a portfolio of ingredients spanning 4 product lines: DermalRx, a range that addresses skin renewal, anti-aging, and moisturization; Pleiotanicals, multifunctional plant-derived actives; HEDI, a line of ingredients made with high energy sonic technology; and a small line of what the company calls Advanced Solutions, ingredients that leverage leading-edge tech from in and beyond the company to meet nuanced market needs.
Now, in partnership with Felis Biotechnology, Biocogent the company has plans to develop skin care ingredients that eliminate or regulate what they’re calling “problematic bacteria” while leaving the “beneficial bacteria” undisturbed.
